Fig4tm1(NCOM)Mfgc
Targeted Allele Detail
|
Symbol: |
Fig4tm1(NCOM)Mfgc |
Name: |
FIG4 phosphoinositide 5-phosphatase; targeted mutation 1, Mammalian Functional Genomics Centre |
MGI ID: |
MGI:4880551 |
Gene: |
Fig4 Location: Chr10:41064168-41179237 bp, - strand Genetic Position: Chr10, 22.08 cM
|
IMPC: |
Fig4 gene page |
|
Mutant Cell Lines: |
N02174P1_C_206W_A5, N02174P1_C_206W_F5 |
Germline Transmission: |
Unknown
|
Parent Cell Line: |
C2 (Tcp) (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
NorCOMM
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_GOHANU
|
|
|
Mutation details: The insertion of NorCOMM cassette pGOHANU created a deletion of size 6032bp between positions 41143412-41149444 of Chromosome 10 (Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an F3 site followed by a universal inverse PCR primer site, splice acceptor IRES-lacZ sequence and a loxP site. This first loxP site is followed by deltaTK and neomycin under the control of the human beta-actin promoter / deltaTK / neomycin phosphotransferase (neoR) gene / SV40 polyA and a second loxP site. After the second loxP site is a PhiC31 attP site and a puromycin sequence that is not active unless a promoter is inserted by PhiC31 at the attP site. The cassette is finished with an FRT site. Variations of this allele can be made using PhiC31 docking and subsequent cloning (Nagy et al., 2009. Methods Mol. Biol. 530:365-78).
(J:165964)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Fig4 Mutation: |
53 strains or lines available
|
|
Original: |
J:165964 Mammalian Functional Genomics Centre, Alleles produced for the NorCOMM project by the Mammalian Functional Genomics Centre (Mfgc), University of Manitoba. MGI Direct Data Submission. 2010; |
All: |
1 reference(s) |
|